Like what that one dissimilarity is, is its a very high intensity of it
So next time someone says, Drinks tonight? you can show up confident, enjoy your friends, and savor the moment, because the new happy hour isnt just about whats in your glass, but how good you feel after
Merck's MK-0893, a small-molecule GCGR antagonist, reached Phase 2b in type 2 diabetes and showed meaningful HbA1c reductions - alongside dose-dependent LDL cholesterol increases, transaminase elevations, and modest weight gain that together made the molecule untenable as a chronic medicine
Retatrutide started low and stepped up monthly the way the trial escalation tables do, sitting in the mid single-digit milligram range once I was comfortable
But Pennsylvania isnt alone in pursuing the policy shift